시장조사 보고서 : 세계의 수두 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Varicella Vaccine Market Growth 2021-2026
	■ 상품코드 : LPI-2201K02212 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 99 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 수두 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (주사, 동결 건조 분말)와 용도별 시장규모 (아동용 주사, 성인용 주사) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 수두 백신 시장 점유율
- 지역별 수두 백신 시장규모
- 주요지역의 종류별 시장규모 (주사, 동결 건조 분말)
- 주요지역의 용도별 시장규모 (아동용 주사, 성인용 주사)
- 미주의 수두 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 수두 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 수두 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 수두 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 수두 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Varicella Vaccine will have significant change from previous year. By the most conservative estimates of global Varicella Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3787.8 million in 2020. Over the next five years the Varicella Vaccine market will register a 8.1% CAGR in terms of revenue, the global market size will reach US$ 5170.7 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Injection
Freeze-Dried Powder

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Kids Injection
Adults Injection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Varicella Vaccine Consumption 2016-2026
2.1.2 Varicella Vaccine Consumption CAGR by Region
2.2 Varicella Vaccine Segment by Type
2.2.1 Injection
2.2.2 Freeze-Dried Powder
2.3 Varicella Vaccine Sales by Type
2.3.1 Global Varicella Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Varicella Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Varicella Vaccine Sale Price by Type (2016-2021)
2.4 Varicella Vaccine Segment by Application
2.4.1 Kids Injection
2.4.2 Adults Injection
2.5 Varicella Vaccine Sales by Application
2.5.1 Global Varicella Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Varicella Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Varicella Vaccine Sale Price by Application (2016-2021)

3 Global Varicella Vaccine by Company
3.1 Global Varicella Vaccine Sales Market Share by Company
3.1.1 Global Varicella Vaccine Sales by Company (2019-2021)
3.1.2 Global Varicella Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Varicella Vaccine Revenue Market Share by Company
3.2.1 Global Varicella Vaccine Revenue by Company (2019-2021)
3.2.2 Global Varicella Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Varicella Vaccine Sale Price by Company
3.4 Global Manufacturers Varicella Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Vaccine Product Location Distribution
3.4.2 Players Varicella Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Varicella Vaccine by Region
4.1 Global Varicella Vaccine by Region
4.1.1 Global Varicella Vaccine Sales by Region
4.1.2 Global Varicella Vaccine Revenue by Region
4.2 Americas Varicella Vaccine Sales Growth
4.3 APAC Varicella Vaccine Sales Growth
4.4 Europe Varicella Vaccine Sales Growth
4.5 Middle East & Africa Varicella Vaccine Sales Growth

5 Americas
5.1 Americas Varicella Vaccine Sales by Country
5.1.1 Americas Varicella Vaccine Sales by Country (2016-2021)
5.1.2 Americas Varicella Vaccine Revenue by Country (2016-2021)
5.2 Americas Varicella Vaccine Sales by Type
5.3 Americas Varicella Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Varicella Vaccine Sales by Region
6.1.1 APAC Varicella Vaccine Sales by Region (2016-2021)
6.1.2 APAC Varicella Vaccine Revenue by Region (2016-2021)
6.2 APAC Varicella Vaccine Sales by Type
6.3 APAC Varicella Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Varicella Vaccine by Country
7.1.1 Europe Varicella Vaccine Sales by Country (2016-2021)
7.1.2 Europe Varicella Vaccine Revenue by Country (2016-2021)
7.2 Europe Varicella Vaccine Sales by Type
7.3 Europe Varicella Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Varicella Vaccine by Country
8.1.1 Middle East & Africa Varicella Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Varicella Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Varicella Vaccine Sales by Type
8.3 Middle East & Africa Varicella Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Varicella Vaccine Distributors
10.3 Varicella Vaccine Customer

11 Global Varicella Vaccine Market Forecast
11.1 Global Varicella Vaccine Forecast by Region
11.1.1 Global Varicella Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Varicella Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Varicella Vaccine Forecast by Type
11.7 Global Varicella Vaccine Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck Varicella Vaccine Product Offered
12.1.3 Merck Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Main Business Overview
12.1.5 Merck Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Varicella Vaccine Product Offered
12.2.3 GSK Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Shanghai Institute
12.3.1 Shanghai Institute Company Information
12.3.2 Shanghai Institute Varicella Vaccine Product Offered
12.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Shanghai Institute Main Business Overview
12.3.5 Shanghai Institute Latest Developments
12.4 BCHT
12.4.1 BCHT Company Information
12.4.2 BCHT Varicella Vaccine Product Offered
12.4.3 BCHT Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 BCHT Main Business Overview
12.4.5 BCHT Latest Developments
12.5 Changsheng
12.5.1 Changsheng Company Information
12.5.2 Changsheng Varicella Vaccine Product Offered
12.5.3 Changsheng Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Changsheng Main Business Overview
12.5.5 Changsheng Latest Developments
12.6 Keygen
12.6.1 Keygen Company Information
12.6.2 Keygen Varicella Vaccine Product Offered
12.6.3 Keygen Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Keygen Main Business Overview
12.6.5 Keygen Latest Developments
12.7 Green Cross
12.7.1 Green Cross Company Information
12.7.2 Green Cross Varicella Vaccine Product Offered
12.7.3 Green Cross Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Green Cross Main Business Overview
12.7.5 Green Cross Latest Developments
12.8 Biken
12.8.1 Biken Company Information
12.8.2 Biken Varicella Vaccine Product Offered
12.8.3 Biken Varicella Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Biken Main Business Overview
12.8.5 Biken Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Varicella Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Freeze-Dried Powder
Table 4. Global Varicella Vaccine Sales by Type (2016-2021) & (M Doses)
Table 5. Global Varicella Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global Varicella Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Varicella Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global Varicella Vaccine Sale Price by Type (2016-2021)
Table 9. Global Varicella Vaccine Sales by Application (2016-2021) & (M Doses)
Table 10. Global Varicella Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global Varicella Vaccine Value by Application (2016-2021)
Table 12. Global Varicella Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global Varicella Vaccine Sale Price by Application (2016-2021)
Table 14. Global Varicella Vaccine Sales by Company (2019-2021) & (M Doses)
Table 15. Global Varicella Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global Varicella Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Varicella Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global Varicella Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Varicella Vaccine Producing Area Distribution and Sales Area
Table 20. Players Varicella Vaccine Products Offered
Table 21. Varicella Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Varicella Vaccine Sales by Region (2016-2021) (M Doses)
Table 25. Global Varicella Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global Varicella Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Varicella Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas Varicella Vaccine Sales by Country (2016-2021) & (M Doses)
Table 29. Americas Varicella Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas Varicella Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Varicella Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas Varicella Vaccine Sales by Type (2016-2021) & (M Doses)
Table 33. Americas Varicella Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas Varicella Vaccine Sales by Application (2016-2021) & (M Doses)
Table 35. Americas Varicella Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC Varicella Vaccine Sales by Region (2016-2021) & (M Doses)
Table 37. APAC Varicella Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC Varicella Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Varicella Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC Varicella Vaccine Sales by Type (2016-2021) & (M Doses)
Table 41. APAC Varicella Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC Varicella Vaccine Sales by Application (2016-2021) & (M Doses)
Table 43. APAC Varicella Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe Varicella Vaccine Sales by Country (2016-2021) & (M Doses)
Table 45. Europe Varicella Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe Varicella Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Varicella Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe Varicella Vaccine Sales by Type (2016-2021) & (M Doses)
Table 49. Europe Varicella Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe Varicella Vaccine Sales by Application (2016-2021) & (M Doses)
Table 51. Europe Varicella Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Varicella Vaccine Sales by Country (2016-2021) & (M Doses)
Table 53. Middle East & Africa Varicella Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Varicella Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Varicella Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Varicella Vaccine Sales by Type (2016-2021) & (M Doses)
Table 57. Middle East & Africa Varicella Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Varicella Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Middle East & Africa Varicella Vaccine Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Varicella Vaccine
Table 61. Key Application and Potential Industries of Varicella Vaccine
Table 62. Key Challenges of Varicella Vaccine
Table 63. Key Trends of Varicella Vaccine
Table 64. Varicella Vaccine Distributors List
Table 65. Varicella Vaccine Customer List
Table 66. Global Varicella Vaccine Sales Forecast by Region (2021-2026) & (M Doses)
Table 67. Global Varicella Vaccine Consumption Market Forecast by Region
Table 68. Global Varicella Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Varicella Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Varicella Vaccine Sales Forecast by Country (2021-2026) & (M Doses)
Table 71. Americas Varicella Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Varicella Vaccine Sales Forecast by Region (2021-2026) & (M Doses)
Table 73. APAC Varicella Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Varicella Vaccine Sales Forecast by Country (2021-2026) & (M Doses)
Table 75. Europe Varicella Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Varicella Vaccine Sales Forecast by Country (2021-2026) & (M Doses)
Table 77. Middle East & Africa Varicella Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Varicella Vaccine Sales Forecast by Type (2021-2026) & (M Doses)
Table 79. Global Varicella Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Varicella Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Varicella Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Varicella Vaccine Sales Forecast by Application (2021-2026) & (M Doses)
Table 83. Global Varicella Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Varicella Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Varicella Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 86. Merck Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck Varicella Vaccine Product Offered
Table 88. Merck Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. GSK Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. GSK Varicella Vaccine Product Offered
Table 93. GSK Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 94. GSK Main Business
Table 95. GSK Latest Developments
Table 96. Shanghai Institute Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Shanghai Institute Varicella Vaccine Product Offered
Table 98. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 99. Shanghai Institute Main Business
Table 100. Shanghai Institute Latest Developments
Table 101. BCHT Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. BCHT Varicella Vaccine Product Offered
Table 103. BCHT Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 104. BCHT Main Business
Table 105. BCHT Latest Developments
Table 106. Changsheng Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Changsheng Varicella Vaccine Product Offered
Table 108. Changsheng Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 109. Changsheng Main Business
Table 110. Changsheng Latest Developments
Table 111. Keygen Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Keygen Varicella Vaccine Product Offered
Table 113. Keygen Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 114. Keygen Main Business
Table 115. Keygen Latest Developments
Table 116. Green Cross Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Green Cross Varicella Vaccine Product Offered
Table 118. Green Cross Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 119. Green Cross Main Business
Table 120. Green Cross Latest Developments
Table 121. Biken Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. Biken Varicella Vaccine Product Offered
Table 123. Biken Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 124. Biken Main Business
Table 125. Biken Latest Developments
List of Figures
Figure 1. Picture of Varicella Vaccine
Figure 2. Varicella Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Vaccine Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Varicella Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Varicella Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Freeze-Dried Powder
Figure 11. Global Varicella Vaccine Sales Market Share by Type in 2020
Figure 12. Global Varicella Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. Varicella Vaccine Consumed in Kids Injection
Figure 14. Global Varicella Vaccine Market: Kids Injection (2016-2021) & (M Doses)
Figure 15. Varicella Vaccine Consumed in Adults Injection
Figure 16. Global Varicella Vaccine Market: Adults Injection (2016-2021) & (M Doses)
Figure 17. Global Varicella Vaccine Sales Market Share by Application (2016-2021)
Figure 18. Global Varicella Vaccine Revenue Market Share by Application in 2020
Figure 19. Varicella Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Varicella Vaccine Revenue Market Share by Company in 2020
Figure 21. Global Varicella Vaccine Sales Market Share by Regions (2016-2021)
Figure 22. Global Varicella Vaccine Revenue Market Share by Region in 2020
Figure 23. Americas Varicella Vaccine Sales 2016-2021 (M Doses)
Figure 24. Americas Varicella Vaccine Revenue 2016-2021 ($ Millions)
Figure 25. APAC Varicella Vaccine Sales 2016-2021 (M Doses)
Figure 26. APAC Varicella Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. Europe Varicella Vaccine Sales 2016-2021 (M Doses)
Figure 28. Europe Varicella Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Varicella Vaccine Sales 2016-2021 (M Doses)
Figure 30. Middle East & Africa Varicella Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Americas Varicella Vaccine Sales Market Share by Country in 2020
Figure 32. Americas Varicella Vaccine Revenue Market Share by Country in 2020
Figure 33. Americas Varicella Vaccine Sales Market Share by Type in 2020
Figure 34. Americas Varicella Vaccine Sales Market Share by Application in 2020
Figure 35. United States Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Varicella Vaccine Sales Market Share by Region in 2020
Figure 40. APAC Varicella Vaccine Revenue Market Share by Regions in 2020
Figure 41. APAC Varicella Vaccine Sales Market Share by Type in 2020
Figure 42. APAC Varicella Vaccine Sales Market Share by Application in 2020
Figure 43. China Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Varicella Vaccine Sales Market Share by Country in 2020
Figure 50. Europe Varicella Vaccine Revenue Market Share by Country in 2020
Figure 51. Europe Varicella Vaccine Sales Market Share by Type in 2020
Figure 52. Europe Varicella Vaccine Sales Market Share by Application in 2020
Figure 53. Germany Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Varicella Vaccine Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Varicella Vaccine Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Varicella Vaccine Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Varicella Vaccine Sales Market Share by Application in 2020
Figure 62. Egypt Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Varicella Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles

※본 조사보고서 [세계의 수두 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02212) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 수두 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 백신 시장예측 2021년-2026년
LPI-2201K02208 / LP Information / 2021년 12월 / 본 조사보고서는 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Vaccine will have significant change from previous year. By the most conservative estimates of global Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next...

세계의 비강 스프레이 인플루엔자 백신 시장예측 2021년-2026년
LPI-2201K02102 / LP Information / 2021년 12월 / 본 조사보고서는 비강 스프레이 인플루엔자 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Nasal Spray Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Nasal Spray Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 폐렴구균 백신 시장예측 2021년-2026년
LPI-2201K02154 / LP Information / 2021년 12월 / 본 조사보고서는 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pneumococcal Bacteria Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Bacteria Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 종양 세포 백신 시장예측 2021년-2026년
LPI-2201K02666 / LP Information / 2021년 12월 / 본 조사보고서는 종양 세포 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tumour-cell Vaccine will have significant change from previous year. By the most conservative estimates of global Tumour-cell Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년
LPI-2201K02170 / LP Information / 2021년 12월 / 본 조사보고서는 SARS-Cov-2 백신 (베로셀)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of SARS-Cov-2 Vaccine (Vero Cell) will have significant change from previous year. By the most conservative estimates of global SARS-Cov-2 Vaccine (Vero Cell) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 수막구균 백신 시장예측 2021년-2026년
LPI-2201K02087 / LP Information / 2021년 12월 / 본 조사보고서는 수막구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Meningococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Meningococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 245.5 million in 2020. Over...